Takada, M <br/><br/>
The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1992 
 - 182-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/BF00685545  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Chi-Square Distribution<br/>Cisplatin--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>Granulocyte Colony-Stimulating Factor--adverse effects<br/>Humans<br/>Leukocyte Count--drug effects<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Mitomycin--administration & dosage<br/>Neutropenia--blood<br/>Time Factors<br/>Vindesine--administration & dosage